Thyroid cancer occurs three times more frequently in females than in males, and in females
the incidence decreases after menopause. This gender difference suggests that the growth …

Thyroid cancer is the most common neoplasia of the endocrine system and accounts for
approximately 1% of all newly diagnosed cancer cases. Its incidence has rapidly grown over …

The metastatic process in breast cancer is related to the expression of the epithelial-to-
mesenchymal transition transcription factors (EMT-TFs) SNAIL, SLUG, SIP1 and TWIST1 …

Previously, we designed and synthesized a potent NF-κB inhibitor, DHMEQ. Although
DHMEQ showed potent anti-inflammatory and anticancer activities in animals, its molecular …

The BRAF V600E mutation is closely linked to tumorigenesis and malignant phenotype of
papillary thyroid cancer. Signaling pathways activated by BRAFV600E are still unclear …

Resistance to chemotherapy predicts an unfavorable outcome for patients with radioiodine-
insensitive thyroid cancer. To investigate the mechanisms underlying this resistance, we …

Background: Although T-cell immunity is thought to be involved in the prognosis of epithelial
ovarian cancer (EOC) patients, immunosuppressive conditions hamper antitumour immune …

Thyroid cancer is the most common endocrine carcinoma with increasing incidence
worldwide and anaplastic subtypes are frequently associated with cancer related death …

Background: Anaplastic thyroid carcinoma (ATC) is one of the most aggressive and
refractory cancers, and a therapy with a new concept needs to be developed. Recently …

NF‐κB is a transcription factor that induces inflammatory cytokines and anti‐apoptotic
proteins. NF‐κB is often constitutively activated in human cancers and leukemias, which …